P G M van der Valk
Overview
Explore the profile of P G M van der Valk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Otters E, Zarafonitis G, Steenbergen E, van der Valk P, Muus P
Br J Dermatol
. 2014 Apr;
171(4):908-10.
PMID: 24701978
No abstract available.
2.
Roelofzen J, van der Valk P, Godschalk R, Dettbarn G, Seidel A, Golsteijn L, et al.
Toxicol Lett
. 2011 Aug;
213(1):39-44.
PMID: 21810456
Coal tar ointments (CTO) are frequently used in the treatment of psoriasis and eczema, but CTO contain carcinogenic polycyclic aromatic hydrocarbons (PAH). PAH are absorbed and metabolized in the skin....
3.
Bovenschen H, Korver J, van der Valk P
Contact Dermatitis
. 2009 Apr;
60(5):290-1.
PMID: 19397623
No abstract available.
4.
de Korte J, van der Valk P, Sprangers M, Damstra R, Kunkeler A, Lijnen R, et al.
Br J Dermatol
. 2007 Dec;
158(2):375-81.
PMID: 18067483
Background: Calcipotriol ointment and short-contact dithranol cream therapy are well-established topical treatments for psoriasis. Quality of life, i.e. the physical, psychological, and social functioning and well-being of the patient, has...
5.
Evers A, Duller P, van de Kerkhof P, van der Valk P, de Jong E, Gerritsen M, et al.
Br J Dermatol
. 2007 Nov;
158(1):101-8.
PMID: 17999699
Background: In dermatological research and clinical practice, there is a need for comprehensive self-report instruments that assess a broad spectrum of health implications of chronic skin diseases, including generic and...
6.
Verhoeven E, Kraaimaat F, van de Kerkhof P, van Weel C, Duller P, van der Valk P, et al.
Br J Dermatol
. 2007 May;
156(6):1346-9.
PMID: 17535233
Background: Physical symptoms of skin diseases have been shown to negatively affect patients' wellbeing. Although insight into physical symptoms accompanying skin diseases is relevant for the management and treatment of...
7.
Verhoeven E, Kraaimaat F, van de Kerkhof P, van Weel C, Duller P, van der Valk P, et al.
J Eur Acad Dermatol Venereol
. 2007 Apr;
21(5):662-8.
PMID: 17447981
Background: Skin diseases are a substantial part of the problems dealt with by general practitioners. Although the psychosocial consequences of skin diseases in secondary care has been extensively studied, little...
8.
van de Kerkhof P, van der Valk P, Swinkels O, Kucharekova M, de Rie M, de Vries H, et al.
Br J Dermatol
. 2006 Sep;
155(4):800-7.
PMID: 16965431
Background: Calcipotriol has become a first-line treatment for psoriasis. Its efficacy and safety have been shown in many comparative clinical trials carried out in outpatients. In a comparative study in...
9.
Evers A, Lu Y, Duller P, van der Valk P, Kraaimaat F, van de Kerkhof P
Br J Dermatol
. 2005 Jun;
152(6):1275-81.
PMID: 15948993
Background: Chronic skin diseases, such as atopic dermatitis and psoriasis, are known to affect quality of life by heightening psychological distress. Knowledge about factors contributing to psychological distress is essential...
10.
Kroft E, Erceg A, Maimets K, Vissers W, van der Valk P, van de Kerkhof P
J Eur Acad Dermatol Venereol
. 2005 Mar;
19(2):249-51.
PMID: 15752305
Recently, tacrolimus ointment has proved to be effective and well tolerated in patients with facial psoriasis. A few months ago we had the opportunity to treat a patient with tacrolimus...